33(top 2%)
papers
837(top 2%)
citations
15(top 2%)
h-index
28(top 2%)
g-index
37
all documents
871
doc citations
366
citing journals

Top Articles

#TitleJournalYearCitations
1Clinical application of the PFA-100®Current Opinion in Hematology2002165
2Contemporary platelet function testingClinical Chemistry and Laboratory Medicine201084
3The LOC387715 Polymorphism, Inflammatory Markers, Smoking, and Age-Related Macular DegenerationOphthalmology200859
4Plerixafor (AMD3100) induces prolonged mobilization of acute lymphoblastic leukemia cells and increases the proportion of cycling cells in the blood in miceExperimental Hematology201352
5Circulating Inflammatory Markers and Hemostatic Factors in Age-Related Maculopathy: A Population-Based Case–Control StudyExperimental Hematology200748
6Laboratory assays for von Willebrand Factor: relative contribution to the diagnosis of von Willebrand’s diseasePathology199745
7Autologous stem cell transplantation in adults with acute lymphoblastic leukemia in first complete remission: analysis of the LALA-85, -87 and -94 trialsLeukemia200642
8Comparable outcomes with marrow or peripheral blood as stem cell sources for hematopoietic cell transplantation from haploidentical donors after non-ablative conditioning: a matched-pair analysisBone Marrow Transplantation201639
9Clinical utility of anticardiolipin antibody assays: high inter-laboratory variation and limited consensus by participants of external quality assurance programs signals a cautious approachPathology199936
10Laboratory reporting of hemostasis assays: the final post-analytical opportunity to reduce errors of clinical diagnosis in hemostasis?Clinical Chemistry and Laboratory Medicine201033
11Pharmacogenetics of vitamin K antagonists: useful or hype?Clinical Chemistry and Laboratory Medicine200931
12The Journal Impact Factor: don't expect its demise any time soonClinical Chemistry and Laboratory Medicine200929
13Laboratory testing in pharmaciesClinical Chemistry and Laboratory Medicine201027
14Evaluation of point-of-care testing in critically unwell patients: comparison with clinical laboratory analysers and applicability to patients with Ebolavirus infectionPathology201518
15The MDA-180 coagulation analyser: a laboratory evaluationPathology199716
16Template bleeding time and PFA-100R have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study of 148 patients - a rebuttalJournal of Thrombosis and Haemostasis200416
17Laboratory medicine and natural disasters: are we ready for the challenge?Clinical Chemistry and Laboratory Medicine201016
18Rapid diagnosis of hemochromatosis gene Cys282Tyr mutation by SSCP analysisClinical Chemistry and Laboratory Medicine199814
19Gender related issues in thrombosis and hemostasisExpert Review of Hematology201714
20Upfront Imatinib Therapy in CML Patients with Rapid Switching to Nilotinib for Failure to Achieve Molecular Targets or Intolerance Achieves High Overall Rates of Molecular Response and a Low Risk of Progression - An Update of the TIDEL-II TrialBlood201114
21Potential laboratory misdiagnosis of hemophilia and von Willebrand disorder owing to cold activation of blood samples for testingAmerican Journal of Clinical Pathology200413
22The missing link between genotype, phenotype and clinicsBiochemia Medica012
23Sweet's syndrome in hairy cell leukemiaJournal of the American Academy of Dermatology198911
24Donor T cells for CAR T cell therapyBiomarker Research20229
25Priming Leukemia with 5-Azacytidine Enhances CAR T Cell TherapyImmunoTargets and Therapy20217
26Selective Escalation of Imatinib Therapy and Early Switching to Nilotinib In De Novo Chronic Phase CML Patients: Interim Results From the TIDEL-II TrialBlood20107
27Aminopeptidase-N (CD13; gp 150): Contrasting patterns of enzymatic activity in blood from patients with myeloid or lymphoid leukemiaLeukemia Research19955
28The indirect estimation of hemoglobin concentration in whole bloodPathology19912
29Maintaining Imatinib ≥600 Mg Daily in the First 12 Months of Chronic Phase CML Treatment Is Associated with Superior Event-Free Survival at 5 Years.Blood20092
30The Wnt/β-Catenin Pathway Promotes Growth and Survival of Acute Lymphoblastic Leukaemia (ALL) Cells In Vitro.Blood20051
31Monocytes Are Associated with Impaired T-Cell Immunity and Residual Interim-PET/CT Avidity After 4 Cycles of CHOP-R In Patients with High-Risk DLBCL,Blood20111
32Bortezomib-Based Induction Overcomes Effect of 1q Amplification On Response in Newly-Diagnosed Myeloma and Results in Similar 2 Year Event-Free SurvivalBlood20121
33Laboratory Evaluation of von Willebrand Disease: Phenotypic AnalysisBlood20090
34Unique case involving chromosomes 3 and 11 in myelodysplastic syndromes (MDS) confirmed by microarray studiesPathology20170